New Review Finds Rhinoplasty Outcome Measures May Miss Breathing Function

Esteworld issues 2026 patient guidance emphasizing that appearance and nasal function should be assessed together

ISTANBUL – 19th August 2026 – Esteworld Health Group has released updated guidance for international patients considering rhinoplasty in Türkiye following new research that identified gaps in how the results of nose surgery are measured.

A systematic review published in Plastic and Reconstructive Surgery analyzed 12 randomized controlled trials involving 743 rhinoplasty patients. The researchers identified 10 different patient-reported outcome measures used to evaluate surgery. Although FACE-Q met 19 of 21 development standards and was the most robust tool for aesthetic assessment, it did not capture functional outcomes such as nasal airflow and breathing.

The authors concluded that existing measurement tools vary substantially and do not fully address both the aesthetic and functional demands of rhinoplasty. They called for either refinement of current measures or the development of a dedicated instrument capable of evaluating both areas.

The findings are significant in a procedure performed at high volume internationally. The International Society of Aesthetic Plastic Surgery’s 2024 Global Survey recorded more than one million rhinoplasty procedures worldwide, although the total was approximately 10% lower than in 2023. The survey reported that 60.1% of rhinoplasties were performed on people aged 18–34 and listed Türkiye among the countries with the highest proportions of international patients across aesthetic procedures.

Esteworld’s guidance responds to the research by advising patients to discuss appearance and nasal function as separate but connected parts of the consultation. Requests involving a dorsal hump, tip shape, deviation or facial proportion should be assessed alongside breathing difficulty, previous trauma, septal deviation, allergies and earlier nasal surgery.

The proposed result should also be considered in relation to the entire face. Skin thickness, cartilage strength, tip support, nasal length, facial width and chin projection can influence what changes are anatomically achievable and proportionate. Reference images and digital simulations may support communication, but they cannot determine suitability or guarantee a result.

The guidance explains that terms such as open, closed, primary and revision rhinoplasty describe different surgical circumstances rather than fixed packages. The recommended approach should follow an examination of nasal anatomy, structural support, previous surgery and functional concerns. Revision cases may involve scar tissue or reduced cartilage support and can require different planning.

International patients are advised to obtain a written plan before booking travel. It should identify the operating surgeon, hospital and anesthesia arrangements, expected length of stay, scheduled postoperative reviews, fitness-to-fly guidance, remote follow-up and any services that may create additional costs.

Patients should also receive balanced information about recovery and risk. Swelling, bruising, congestion and temporary sensory changes can occur, while less common complications include bleeding, infection, scarring, asymmetry, persistent breathing problems or the need for further treatment. Final appearance should not be judged during early recovery, as residual swelling can continue for months.

The full guidance is educational and does not replace an individual medical consultation. Rhinoplasty is not appropriate for every patient, and neither aesthetic nor functional improvement can be guaranteed.

About Esteworld

Esteworld Health Group has provided services in plastic surgery, hair transplantation, medical aesthetics, dental treatments and longevity in Istanbul since 1994. Rhinoplasty plans are determined following assessment by relevant healthcare professionals.

Media Contact

Esteworld Health Group

Email: info@esteworldturkey.com

Phone: +90 216 474 54 54

Website: www.esteworldturkey.com

SOURCE: Esteworld Health Group